DNAJC5 and malaria: Over the five years of the study, the incidence of clinical malaria was lower in children with an anti-CSP IgG antibody titre in the highest tercile compared to that in children with a titre in the lowest tercile (Incidence rate per 1000 person years at risk (PYAR), 191.6 [95%CI, 154.1–235.6] and 354 [95% CI, 301.3–413.3]) respectively.